Paul W. Collins

829 total citations
19 papers, 648 citations indexed

About

Paul W. Collins is a scholar working on Organic Chemistry, Pharmacology and Analytical Chemistry. According to data from OpenAlex, Paul W. Collins has authored 19 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 6 papers in Pharmacology and 6 papers in Analytical Chemistry. Recurrent topics in Paul W. Collins's work include Inflammatory mediators and NSAID effects (5 papers), Analytical Methods in Pharmaceuticals (5 papers) and Synthetic Organic Chemistry Methods (3 papers). Paul W. Collins is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Analytical Methods in Pharmaceuticals (5 papers) and Synthetic Organic Chemistry Methods (3 papers). Paul W. Collins collaborates with scholars based in United States and Canada. Paul W. Collins's co-authors include Stevan W. Djurić, William E. Perkins, Richard M. Weier, Alan F. Gasiecki, Daniel P. Becker, Carol M. Koboldt, Jaime L. Masferrer, Amy W. Veenhuizen, Francis J. Koszyk and Peter C. Isakson and has published in prestigious journals such as Chemical Reviews, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Paul W. Collins

18 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul W. Collins United States 11 418 140 140 48 44 19 648
Simon Peace United Kingdom 14 440 1.1× 208 1.5× 28 0.2× 11 0.2× 103 2.3× 22 647
Robert G. Bianchi United States 13 150 0.4× 95 0.7× 200 1.4× 13 0.3× 7 0.2× 42 537
Shinsuke Hashimoto Japan 12 309 0.7× 116 0.8× 46 0.3× 74 1.5× 26 0.6× 23 475
Edward H. Wiseman United States 13 622 1.5× 285 2.0× 181 1.3× 12 0.3× 56 1.3× 32 927
Hans Wissmann Germany 10 217 0.5× 283 2.0× 38 0.3× 10 0.2× 35 0.8× 18 464
A. A. PATCHETT United States 13 237 0.6× 339 2.4× 72 0.5× 5 0.1× 34 0.8× 25 664
Alain Daugan France 9 272 0.7× 366 2.6× 69 0.5× 53 1.1× 25 0.6× 9 595
Michael E. Solomon United States 9 386 0.9× 520 3.7× 128 0.9× 16 0.3× 19 0.4× 12 835
John C. Liao United States 15 176 0.4× 317 2.3× 99 0.7× 57 1.2× 217 4.9× 23 744
Lars‐Inge Olsson Sweden 15 312 0.7× 81 0.6× 38 0.3× 10 0.2× 43 1.0× 27 513

Countries citing papers authored by Paul W. Collins

Since Specialization
Citations

This map shows the geographic impact of Paul W. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul W. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul W. Collins more than expected).

Fields of papers citing papers by Paul W. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul W. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul W. Collins. The network helps show where Paul W. Collins may publish in the future.

Co-authorship network of co-authors of Paul W. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Paul W. Collins. A scholar is included among the top collaborators of Paul W. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul W. Collins. Paul W. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Khanna, Ish, Richard M. Weier, Yi Yu, et al.. (1997). 1,2-Diarylimidazoles as Potent, Cyclooxygenase-2 Selective, and Orally Active Antiinflammatory Agents. Journal of Medicinal Chemistry. 40(11). 1634–1647. 138 indexed citations
2.
Roston, Daryl A., et al.. (1995). Supercritical fluid extraction-liquid chromatography method development for a polymeric controlled-release drug formulation. Journal of Pharmaceutical and Biomedical Analysis. 13(12). 1513–1520. 4 indexed citations
3.
Becker, Daniel P., et al.. (1993). Isolation of a highly functionalized Tröger's base derivative via a novel reaction. Tetrahedron Letters. 34(12). 1889–1892. 26 indexed citations
4.
Collins, Paul W. & Stevan W. Djurić. (1993). Synthesis of therapeutically useful prostaglandin and prostacyclin analogs. Chemical Reviews. 93(4). 1533–1564. 265 indexed citations
5.
Tremont, Samuel J., Paul W. Collins, William E. Perkins, et al.. (1993). Catalytic functionalization of polymers: a novel approach to site-specific delivery of misoprostol to the stomach. Journal of Medicinal Chemistry. 36(21). 3087–3097. 15 indexed citations
6.
Cavell, Ronald G., et al.. (1993). Heterobifunctional Phosphorus-Nitrogen Compounds: Iminophosphoranophosphines and Their Complexes. Phosphorus, sulfur, and silicon and the related elements. 76(1-4). 9–12. 9 indexed citations
7.
Collins, Paul W., Robert L. Shone, William E. Perkins, et al.. (1992). Synthesis and structure-activity relationships of acyclic .omega. chain conjugated diene analogs of enisoprost. Journal of Medicinal Chemistry. 35(4). 694–704. 4 indexed citations
8.
Widomski, D. L., David Baron, Máté Hídvégi, et al.. (1991). Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes. Inflammation Research. 34(1-2). 30–31. 18 indexed citations
9.
Collins, Paul W.. (1990). Misoprostol: Discovery, development, and clinical applications. Medicinal Research Reviews. 10(2). 149–172. 77 indexed citations
10.
Collins, Paul W., Alan F. Gasiecki, William E. Perkins, et al.. (1990). Chemistry and structure-activity relationships of C-17 unsaturated 18-cycloalkyl and cycloalkenyl analogs of enisoprost. Identification of a promising new antiulcer prostaglandin. Journal of Medicinal Chemistry. 33(10). 2784–2793. 10 indexed citations
11.
Kalish, Vincent J., Robert L. Shone, Steven W. Kramer, et al.. (1990). An Improved Procedure for the Synthesis of Prostaglandin Analogues. Synthetic Communications. 20(11). 1641–1645. 2 indexed citations
12.
Collins, Paul W., Alan F. Gasiecki, Richard M. Weier, et al.. (1987). Alpha chain unsaturated derivatives of misoprostol. Prostaglandins. 33. 17–28. 2 indexed citations
13.
Collins, Paul W., Steven W. Kramer, Alan F. Gasiecki, et al.. (1987). Synthesis and gastrointestinal pharmacology of a 3E,5Z diene analog of misoprostol. Journal of Medicinal Chemistry. 30(1). 193–197. 15 indexed citations
14.
Collins, Paul W., Alan F. Gasiecki, Peter H. Jones, et al.. (1986). Synthesis and gastric antisecretory properties of .alpha.-chain diene derivatives of misoprostol. Journal of Medicinal Chemistry. 29(7). 1195–1201. 6 indexed citations
15.
Collins, Paul W., et al.. (1986). ChemInform Abstract: Synthesis and Gastric Antisecretory Properties of α‐Chain Diene Derivatives of Misoprostol.. Chemischer Informationsdienst. 17(48). 1 indexed citations
16.
Collins, Paul W., et al.. (1978). Synthesis of antisecretory prostaglandins using vinyl tin precursors. Tetrahedron Letters. 19(35). 3187–3190. 14 indexed citations
17.
Collins, Paul W., et al.. (1975). Influence of the position of the side chain hydroxy group on the biological properties of prostaglandins. Tetrahedron Letters. 16(48). 4217–4220. 22 indexed citations
18.
Burger, Alfred, Manuel Bernabé, & Paul W. Collins. (1970). 2-(4-Imidazolyl)cyclopropylamine. Journal of Medicinal Chemistry. 13(1). 33–35. 16 indexed citations
19.
Collins, Paul W. & Andrew P. Vayda. (1969). Functional Analysis and its Aims. Journal of Sociology. 5(2). 153–156. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Peace Breakdown of academic impact, for papers by Robert G. Bianchi Breakdown of academic impact, for papers by Shinsuke Hashimoto Breakdown of academic impact, for papers by Edward H. Wiseman Breakdown of academic impact, for papers by Hans Wissmann Breakdown of academic impact, for papers by A. A. PATCHETT Breakdown of academic impact, for papers by Alain Daugan Breakdown of academic impact, for papers by Michael E. Solomon Breakdown of academic impact, for papers by John C. Liao Breakdown of academic impact, for papers by Lars‐Inge Olsson
Rankless by CCL
2026